Evidence map›Paper›PMID 33122236›Full record

ReviewBMJ case reports2020

Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy.

Maria Camprodon Gómez, Carlos González-Cruz, Berta Ferrer, María Jesús Barberá

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in BMJ case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Acro-ischemic lesions in COVID-19 patients: A case series.Journal of cosmetic dermatology · 2022
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maria Camprodon GómezRare Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain camprodon.90@gmail.com.ORCID http://orcid.org/0000-0002-2359-3238
Carlos González-CruzDermatology, Hospital Vall d'Hebron, Barcelona, Spain.ORCID http://orcid.org/0000-0003-0117-8858
Berta FerrerPathology, Hospital Vall d'Hebron, Barcelona, Barcelona, Spain.
María Jesús BarberáInfectious Diseases Department, Hospital Vall d\'Hebron, Barcelona, Catalunya, Spain.
Vall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Main skin manifestations of COVID-19 have been recently classified. However, little is known about cutaneous histopathological patterns and the presence of SARS-CoV-2 in these skin lesions. We present a healthy 29-year-old man who developed a leucocytoclastic vasculitis for COVID-19 with positive SARS-CoV-2 PCR in skin biopsy.

Indexed as

Adrenal Cortex HormonesAdultBiopsy, NeedleCoronavirus InfectionsCOVID-19DNA, ViralHumansImmunohistochemistryMalePandemicsPneumonia, ViralPolymerase Chain ReactionPrognosisTreatment OutcomeVasculitis, Leukocytoclastic, CutaneousAdrenal Cortex HormonesDNA, Viraldermatologyinfectious diseasesvasculitis

Identifiers

PMID33122236
PMCPMC7597471
OpenAlexW3097296091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.